Amare Global Holdings, FTC v.
No reply on file from Amare Global Holdings on this matter.
Claims entered
No claim has been entered on this docket.
1 filed · 1 on the record. The chronology below carries every filing, docket event and outcome — open a row there for its source.
Open to posting — anyone may add to this file, subject to the review queue.
The chronology
Gov, Institution and Public name who produced a document; Event marks a thing that happened, not a document.
By when it happened. Rows with no date on their face are shown as undated, not guessed. Hover, focus or tap a row for its full detail.
Opened at stage filed
The FTC sued multilevel marketer Amare Global Holdings Inc. and three of its principals for misrepresenting to parents and other consumers that its dietary supplements marketed for children and adults could treat or cure health conditions such as depression, anxiety and ADHD, and for misleading its seller recruits about their potential earnings as “brand partners.” The Federal Trade Commission has asked a federal court to hold in contempt dietary supplement provider Amare Global Holdings as well as its former Chief Science Officer Shawn Talbott and two other individuals over allegations they violated an FTC order in the Window Rock case that banned Talbott and those who work with him from making false, deceptive or unsubstantiated health claims.
No crime, statute, place, status, party or amount is on the record for this docket yet.